Peapod Lane Capital’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Peapod Lane Capital's KRON Position: Q2 2025 in Review
Peapod Lane Capital sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 564,572 shares — an estimated $466K sold.
Peapod Lane Capital first reported a position in KRON in Q4 2024 and held it in 2 quarters. The position peaked at $534K in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Peapod Lane Capital reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Peapod Lane Capital sold 564,572 Kronos Bio shares in Q2 2025, an estimated $466K.
- Peapod Lane Capital first reported a position in Kronos Bio in Q4 2024 and held it in 2 quarters.
- Peapod Lane Capital's Kronos Bio position peaked at $534K in Q4 2024.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Peapod Lane Capital's 13F filing for Q2 2025, filed 31 Jul 2025.